Effect of once ‐weekly semaglutide on the counterregulatory response to hypoglycaemia in subjects with type 2 diabetes: a randomised, placebo‐controlled, double‐blind, crossover trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 12, 2018 Category: Endocrinology Authors: Stefan
Korsatko
,
Lene
Jensen
,
Martina
Brunner
,
Stefanie
Sach ‐Friedl
,
Maja D.
Tarp
,
Anders G.
Holst
,
Simon R.
Heller
,
Thomas R.
Pieber Source Type: research
Effects of liraglutide on gallbladder emptying: a randomised, placebo ‐controlled trial in adults with overweight or obesity
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 12, 2018 Category: Endocrinology Authors: Christina C.
Nex øe‐Larsen
,
Pernille H.
Sørensen
,
Helene
Hausner
,
Mikkel
Agersnap
,
Mille
Baekdal
,
Andreas
Brønden
,
Lea N.
Gustafsson
,
David P.
Sonne
,
Louise
Vedtofte
,
Tina
Vilsbøll
,
Filip K.
Knop Source Type: research
Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: 1 ‐year prospective observational study with suggestions to minimize clinical impact
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 12, 2018 Category: Endocrinology Authors: Ivana
Rabbone
MD, PhD
,
Nicola
Minuto
MD
,
Sonia
Toni
MD
,
Fortunato
Lombardo
MD
,
Dario
Iafusco
MD
,
Marco
Marigliano
MD
,
Riccardo
Schiaffini
MD
,
G.
Maltoni
MD
,
Anna Paola
Frongia
MD
,
Marco
Scardapane
MD
,
Ant Source Type: research
Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: a 12 ‐month comparison by concomitant sulphonylurea and/or glinide use
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Yasuo
Terauchi
,
Matthew C
Riddle
,
Takahisa
Hirose
,
Masayoshi
Koyama
,
Xi
Cheng
,
Yoshinori
Takahashi
,
Geremia B
Bolli Source Type: research
Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes and Moderate Renal Impairment (Chronic Kidney Disease Stage 3A): The DERIVE Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Paola
Fioretto
MD
,
Stefano
Del Prato
MD
,
John B
Buse
MD, PhD
,
Ronald
Goldenberg
MD
,
Francesco
Giorgino
MD
,
Daniel
Reyner
DrPH
,
Anna Maria
Langkilde
MD
,
C. David
Sj ӧstrӧm
MD
,
Peter
Sartipy
PhD
, Source Type: research
Body Mass Index impacts the choice of lipid lowering treatment with no correlation to blood cholesterol – findings from 52,916 patients in the Dyslipidemia International Study (DYSIS)
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Jean
Ferri ères
,
Dominik
Lautsch
,
Anselm K.
Gitt
,
Gaetano
De Ferrari
,
Hermann
Toplak
,
Moses
Elisaf
,
Heinz
Drexel
,
Martin
Horack
,
Carl
Baxter
,
Baishali
Ambegaonkar
,
Philippe
Brudi
,
Peter P.
Toth Source Type: research
A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti ‐HERV‐W‐Env monoclonal antibody
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Francois
Curtin
MD
,
Corinne
Bernard
PhD
,
Sandrine
Levet
PhD
,
Herv é
Perron
PhD
,
Hervé
Porchet
MD
,
Julie
Médina
PhD
,
Sam
Malpass
MSc
,
David
Lloyd
PhD
,
Richard
Simpson
DM
, Source Type: research
Response to the comment on: “Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 trials”
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Richard D.
Leslie
MD
,
Paolo
Pozzilli
MD
,
Anne L.
Peters
MD
,
Raffaella
Buzzetti
,
Sudha S.
Shankar
PhD
,
Zvonko
Milicevic
MD
,
Imre
Pavo
MD
,
Jeremie
Lebrec
PhD
,
Sherry
Martin
MD
,
Nanette C.
Schloot
MD Source Type: research
Variability of insulin degludec and glargine 300 U/mL: A matter of methodology or just marketing?
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Tim
Heise
MD
,
Sascha
Heckermann
,
J.
Hans DeVries
MD Source Type: research
Effect of short ‐term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug‐naïve Japanese patients with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Ryo
Suzuki
MD
,
Jun ‐ichi
Eiki
PhD
,
Takashi
Moritoyo
MD
,
Kenichi
Furihata
MD
,
Akira
Wakana
PhD
,
Yukari
Ohta
BS
,
Shigeru
Tokita
PhD
,
Takashi
Kadowaki
MD Source Type: research
Endogenous GLP ‐1 alters postprandial functional connectivity between homeostatic and reward‐related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Anne Christin
Meyer ‐Gerspach
PhD
,
Huynh Giao
Ly
PhD
,
Stefan
Borgwardt
MD
,
Patrick
Dupont
MD
,
Christoph
Beglinger
MD
,
Lukas
Van Oudenhove
MD
,
Bettina K.
Wölnerhanssen
MD Source Type: research
Semaglutide for type 2 diabetes mellitus: A systematic review and meta ‐analysis
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Panagiotis
Andreadis
MD
,
Thomas
Karagiannis
MD
,
Konstantinos
Malandris
MD
,
Ioannis
Avgerinos
MD
,
Aris
Liakos
MD
,
Apostolos
Manolopoulos
MD
,
Eleni
Bekiari
MD
,
David R
Matthews
MD
,
Apostolos
Tsapas
MD Source Type: research
Efficacy and safety of MK ‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open‐label clinical trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Priscilla A.
Hollander
MD
,
Wendy L.
Carofano
PharmD
,
Raymond L.H.
Lam
PhD
,
Gregory T.
Golm
PhD
,
Roy
Eldor
MD
,
Michael F.
Crutchlow
MD
,
Michael C.
Marcos
MS
,
Marc S.
Rendell
MD
,
Philip D.
Home
DPhil
,
Baptist
Source Type: research
No Effect of Resveratrol on VLDL ‐TG Kinetics and Insulin Sensitivity in Obese Men with Nonalcoholic Fatty Liver Disease
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 9, 2018 Category: Endocrinology Authors: Marianne K.
Poulsen
,
Birgitte
Nellemann
,
Bo Martin
Bibby
,
Hans
St ødkilde‐Jørgensen
,
Steen B.
Pedersen
,
Henning
Grønbæk
,
Søren
Nielsen Source Type: research
Iloprost infusion prevents the insulin ‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 9, 2018 Category: Endocrinology Authors: Anna L.
Emanuel
MD
,
Nicolien C.
de Clercq
MD
,
Annefleur M.
Koopen
MD
,
Erik
van Poelgeest
MD
,
Mireille J.M.
Serlie
MD/PhD
,
Daniel H.
van Raalte
MD/PhD
,
Prof.
Mark H.H.
Kramer
MD
,
Prof.
Max
Nieuwdorp
MD
,
Etto C.
Eri Source Type: research